US20040006248A1 - Process for the preparation of nitroalkenes - Google Patents

Process for the preparation of nitroalkenes Download PDF

Info

Publication number
US20040006248A1
US20040006248A1 US10/311,319 US31131902A US2004006248A1 US 20040006248 A1 US20040006248 A1 US 20040006248A1 US 31131902 A US31131902 A US 31131902A US 2004006248 A1 US2004006248 A1 US 2004006248A1
Authority
US
United States
Prior art keywords
process according
nitration
groups
nitrite
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/311,319
Other languages
English (en)
Inventor
Maurizio Paiocchi
Aldo Belli
Francesco Ponzini
Marco Villa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zach System SpA
Original Assignee
Zambon Group SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA filed Critical Zambon Group SpA
Assigned to ZAMBON GROUP S.P.A. reassignment ZAMBON GROUP S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PONZINI, FRANCESCO, PAIOCCHI, MAURIZIO, VILLA, MARCO, BELLI, ALDO
Publication of US20040006248A1 publication Critical patent/US20040006248A1/en
Priority to US11/247,600 priority Critical patent/US7265251B2/en
Assigned to ZACH SYSTEM S.P.A. reassignment ZACH SYSTEM S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ZAMBON GROUP S.P.A.
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/08Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28Hydrogenated naphthalenes

Definitions

  • the present invention relates to a process for the preparation of nitroalkenes and, more particularly, it relates to a process for the preparation of conjugated ⁇ -nitroalkenes by reaction of a conjugated alkene with a nitrite in the presence of iodine and of an oxidising agent.
  • Conjugated ⁇ -nitroalkenes are widely used synthetic intermediates because they can be easily converted into a variety of different compounds. For example, we can cite ⁇ -nitrostyrene, useful intermediate for the preparation of several phenylethylamines and fungicides (Chemical Abstracts, vol. 118, no.
  • Wing-Wah Sy et al [Tetr. Lett., 1985, 26(9), pages 1193-1196] describe the nitration of substituted alkenes with silver nitrite and iodine, the only difference from Hassner et al being the use of a higher molar amount of silver nitrite, which is then equimolar with respect to the iodine.
  • Jew et al. replace silver nitrite with sodium nitrite and use 2 moles of iodine and 4 moles of nitrite per mole of styrene, respectively.
  • potassium nitrite is used in the presence of a phase transfer catalyst and by treating with ultrasounds in order to increase the solubility of the nitrite ion.
  • Different amounts of iodine were evaluated to optimise the yield and the reported general method foresees the use of 2.6 moles of nitrite and 2.75 moles of iodine per mole of alkene, respectively.
  • object of the present invention is a process for the nitration of conjugated alkenes of formula
  • R is a hydrogen atom, an optionally substituted phenyl, a linear or branched C 1 -C 4 alkyl
  • R 1 is a hydrogen atom or a linear or branched C 1 -C 4 alkyl, optionally substituted by an OH or C 1 -C 4 alkoxy group
  • R 2 , R 3 and R 4 are selected among hydrogen and halogen atoms, linear or branched C 1 -C 4 alkyl or alkoxy groups, carboxylic groups, aminocarbonyl groups, alkyloxycarbonyl, alkylcarbonyl, mono- or di-alkylaminocarbonyl alkylcarbonylamino and alkylcarbonyloxy groups having from 1 to 4 carbon atoms in the alkyl moiety; or two of R 2 , R 3 and R 4 , in ortho between them, form a methylendioxy group; or R 1 together with R 2 forms a cyclic system with 5-7 terms conden
  • the nitrating agent is a mixture of an inorganic nitrite and iodine in the presence of an oxidising agent.
  • the nitration process object of the present invention allows to obtain ⁇ -nitroalkenes under mild conditions with good yields.
  • linear or branched C 1 -C 4 alkyl means an alkyl selected among methyl, ethyl, n-propyl, isopropyl n-butyl sec-butyl isobutyl and t-butyl;
  • linear or branched C 1 -C 4 alkoxy means a group selected among methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy and t-butoxy;
  • halogen means fluorine, chlorine, bromine and iodine.
  • Substituted phenyl means a phenyl substituted by one or more substituents selected among the meanings of R 2 , R 3 and R 4 .
  • Preferred examples of the compounds of formula I are styrenes optionally substituted on the aromatic ring by from 1 to 3 methoxy groups or by a methylenedioxy group, dihydronaphthalenes optionally substituted by methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl groups or by a methylenedioxy group or benzopyranes optionally substituted by methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl, aminocarbonyl or methylaminocarbonyl groups.
  • R 3A and R 4A are hydrogen atoms, methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl groups or, together, form a methylenedioxy group; R has the already reported meanings;
  • R 3B and R 4B are hydrogen atoms, methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl, aminocarbonyl or methylaminocarbonyl groups; R has the already reported meanings;
  • R, R 3A , R 3B , R 4A and R 4B have the already reported meanings.
  • Examples of inorganic nitrites which can be used in the process object of the present invention are silver nitrite, sodium nitrite and potassium nitrite.
  • the amount of nitrite is in excess with respect to the compound of formula I, generally not lower Man 2 moles per mole of compound to be nitrated.
  • nitrite from 2 and 4 moles per mole of compound of formula I is used.
  • the most characterizing feature of the present process is represented by the amount of iodine which is used.
  • an oxidising agent allows to significantly decrease the amount of iodine up to an amount generally equal or lower than 1 mole per mole of compound of formula I, preferably from 0.1 and 0.8 moles per mole of substrate to be nitrated.
  • the oxidation agent is slowly added, usually in 34 hours, to the reaction mixture containing the nitrite, iodine and the compound of formula I.
  • AlkH represents the compound of formula I
  • a further stage is represented by the fact that, by using an oxidising agent, the iodine can also be prepared in situ by oxidation of iodides.
  • Iodides which can be used for such purposes are generally alkali metal iodides, preferably potassium iodide.
  • oxidising agents which can be used in the process object of the present invention are peracids such as peracetic acid and m-chloroperbenzoic acid, oxygen peroxide and inorganic nitrites, optionally in admixture each other.
  • the oxidising agent must be used in an acid environment, preferably at a pH lower than 5.
  • the amount of oxidant will be in relation to the used amount of iodine, preferably in slight excess.
  • a higher amount of oxidant will be needed to allow the initial oxidation of the iodides
  • the process object of the present invention is carried out in the presence of a suitable organic solvent which is selected in relation to the solubility of the compound of formula I but which is not a critical parameter for the achievement of the process.
  • esters such as ethyl acetate, isopropyl acetate and isobutyl acetate
  • aromatic hydrocarbons such as toluene and xylene
  • chlorinated hydrocarbons such as methylene chloride and 1,2-dichloropropane
  • ethers such as tert-butyl methyl ether.
  • reaction mixture contains water
  • addition of a phase transfer catalyst can be. useful.
  • the temperature is not a critical parameter. Preferably temperatures from 20° C. to 70° C. are used. A still more preferred temperature range is from 40° C. to 50° C.
  • a preferred embodiment of the process object of the present invention is the following.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
US10/311,319 2000-06-28 2001-06-19 Process for the preparation of nitroalkenes Abandoned US20040006248A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/247,600 US7265251B2 (en) 2000-06-28 2005-10-12 Process for the preparation of nitroalkenes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00830453.7 2000-06-28
EP00830453 2000-06-28
PCT/EP2001/006902 WO2002000575A1 (en) 2000-06-28 2001-06-19 Process for the preparation of nitroalkenes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/247,600 Continuation US7265251B2 (en) 2000-06-28 2005-10-12 Process for the preparation of nitroalkenes

Publications (1)

Publication Number Publication Date
US20040006248A1 true US20040006248A1 (en) 2004-01-08

Family

ID=8175386

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/311,319 Abandoned US20040006248A1 (en) 2000-06-28 2001-06-19 Process for the preparation of nitroalkenes
US11/247,600 Expired - Fee Related US7265251B2 (en) 2000-06-28 2005-10-12 Process for the preparation of nitroalkenes

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/247,600 Expired - Fee Related US7265251B2 (en) 2000-06-28 2005-10-12 Process for the preparation of nitroalkenes

Country Status (12)

Country Link
US (2) US20040006248A1 (zh)
EP (1) EP1294658B1 (zh)
JP (1) JP4705307B2 (zh)
CN (1) CN1232480C (zh)
AT (1) ATE289986T1 (zh)
AU (1) AU2001278456A1 (zh)
CA (1) CA2412232C (zh)
DE (1) DE60109163T2 (zh)
DK (1) DK1294658T3 (zh)
ES (1) ES2239155T3 (zh)
PT (1) PT1294658E (zh)
WO (1) WO2002000575A1 (zh)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100331268A1 (en) * 2004-04-28 2010-12-30 The Uab Research Foundation Nitrated Lipids and Methods of Making and Using Thereof
US8563609B2 (en) 2010-05-13 2013-10-22 Nitromega Corp. Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
US9585855B2 (en) 2008-06-19 2017-03-07 The University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
US9663444B2 (en) 2009-10-02 2017-05-30 Complexa, Inc. Heteroatom containing substituted fatty acids
US9700534B2 (en) 2007-08-01 2017-07-11 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US9750725B2 (en) 2009-07-31 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9790167B2 (en) 2008-05-01 2017-10-17 Complexa, Inc. Vinyl substituted fatty acids
US10010532B2 (en) 2011-08-19 2018-07-03 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US10369125B2 (en) 2008-06-19 2019-08-06 The University Of Utah Research Foundation Method of treating renal system damage
US10537541B2 (en) 2015-10-02 2020-01-21 Complexa Inc. Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid
US11608342B2 (en) 2015-07-07 2023-03-21 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
US12006319B2 (en) 2018-05-25 2024-06-11 Cardurion Pharmaceuticals, Inc. Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102574768B (zh) * 2009-10-20 2015-07-08 安格斯化学公司 用于通过将水相再循环至硝化反应器以回收硝基烷烃的方法
FR2985999B1 (fr) 2012-01-23 2014-01-31 Arkema France Procede de production d'acrylate de 2-octyle par transesterification
CN105152935A (zh) * 2015-09-06 2015-12-16 安徽理工大学 一种制备β-硝基苯乙烯类化合物的方法
CN107032939B (zh) * 2017-05-17 2020-09-11 沅江华龙催化科技有限公司 α,β-不饱和硝基烯烃衍生物的合成方法
CN106995373B (zh) * 2017-05-17 2019-01-11 沅江华龙催化科技有限公司 以碘化铵为硝基源一锅合成α,β-不饱和硝基烯烃衍生物的方法
CN106995372B (zh) * 2017-05-17 2018-12-18 沅江华龙催化科技有限公司 一种基于四芳基卟啉铁催化合成(E)-β-硝基苯乙烯衍生物的方法
CN107098811B (zh) * 2017-05-17 2019-03-26 沅江华龙催化科技有限公司 (E)-β-硝基苯乙烯的合成方法
CN109970701B (zh) * 2019-04-02 2021-05-04 常州大学 一种用I2O5/NaNO2硝化富电子芳香族化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701438D0 (sv) * 1997-04-17 1997-04-17 Astra Ab A new process

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9867795B2 (en) 2004-04-28 2018-01-16 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US8309526B2 (en) 2004-04-28 2012-11-13 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9006473B2 (en) 2004-04-28 2015-04-14 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9295678B2 (en) 2004-04-28 2016-03-29 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9522156B2 (en) 2004-04-28 2016-12-20 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US20100331268A1 (en) * 2004-04-28 2010-12-30 The Uab Research Foundation Nitrated Lipids and Methods of Making and Using Thereof
US10869850B2 (en) 2007-08-01 2020-12-22 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US10576051B2 (en) 2007-08-01 2020-03-03 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US9700534B2 (en) 2007-08-01 2017-07-11 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US10258589B2 (en) 2007-08-01 2019-04-16 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US9790167B2 (en) 2008-05-01 2017-10-17 Complexa, Inc. Vinyl substituted fatty acids
US9585855B2 (en) 2008-06-19 2017-03-07 The University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
US10369125B2 (en) 2008-06-19 2019-08-06 The University Of Utah Research Foundation Method of treating renal system damage
US10568857B2 (en) 2008-06-19 2020-02-25 The University Of Utah Research Foundation Method of treating renal system damage
US10835518B2 (en) 2009-07-31 2020-11-17 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US10213417B2 (en) 2009-07-31 2019-02-26 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9750725B2 (en) 2009-07-31 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US11723897B2 (en) 2009-07-31 2023-08-15 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9663444B2 (en) 2009-10-02 2017-05-30 Complexa, Inc. Heteroatom containing substituted fatty acids
US8563609B2 (en) 2010-05-13 2013-10-22 Nitromega Corp. Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
US10709690B2 (en) 2011-08-19 2020-07-14 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US10010532B2 (en) 2011-08-19 2018-07-03 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US11608342B2 (en) 2015-07-07 2023-03-21 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
US10537541B2 (en) 2015-10-02 2020-01-21 Complexa Inc. Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid
US12006319B2 (en) 2018-05-25 2024-06-11 Cardurion Pharmaceuticals, Inc. Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

Also Published As

Publication number Publication date
DK1294658T3 (da) 2005-06-27
US20060063953A1 (en) 2006-03-23
ATE289986T1 (de) 2005-03-15
US7265251B2 (en) 2007-09-04
PT1294658E (pt) 2005-07-29
CN1438977A (zh) 2003-08-27
CN1232480C (zh) 2005-12-21
CA2412232A1 (en) 2002-01-03
AU2001278456A1 (en) 2002-01-08
EP1294658A1 (en) 2003-03-26
DE60109163D1 (de) 2005-04-07
JP2004501878A (ja) 2004-01-22
DE60109163T2 (de) 2006-04-13
WO2002000575A1 (en) 2002-01-03
EP1294658B1 (en) 2005-03-02
ES2239155T3 (es) 2005-09-16
JP4705307B2 (ja) 2011-06-22
CA2412232C (en) 2010-03-30

Similar Documents

Publication Publication Date Title
US7265251B2 (en) Process for the preparation of nitroalkenes
IL209691A (en) Biphenyl is converted
CN111662240B (zh) 一种高纯度丙硫菌唑的制备方法
EP0031253B1 (en) Process for preparing 3,4-substituted benzaldehydes
ZA200101507B (en) Method for producing ortho-alkylated benzoic acid derivatives.
US5777172A (en) Process for the preparation of benzophenthiones and benzophenones
JP2009137955A (ja) シクロアルキルおよびハロアルキルo−アミノフエニルケトン類の改良された製造方法
JP4550492B2 (ja) フッ素含有アセトフェノンの製造方法およびその使用
US6943257B2 (en) Process for preparation of aromatic halides from aromatic amines
JP3663229B2 (ja) 4−ハロ−2′−ニトロブチロフエノン化合物の製造方法
EP1295864B1 (en) Process for preparation of 1,5-diaminonaphthalenes
Genin et al. Gold catalysis in organic synthesis: efficient intramolecular cyclization of γ-acetylenic carboxylic acids to 5-exo-alkylidene-butyrolactones
KR100353536B1 (ko) 치환된페닐아세트산유도체의제조방법및신규한중간체
CH589591A5 (en) Aryl-alkane acids production - forming an aldehyde from aryl or alkyl groupings and converting
EP1870392B1 (en) Process for production of 2,3,4-trifluoro-5-(iodo or bromo)benzoic acid
US6121491A (en) Process for the preparation of (+/-)3-(3,4-dichlorophenyl)-2-dimethylamino-2-methylpropan-1-OL or cericlamine (INN)
WO2023080193A1 (ja) インドール化合物の製造方法
EP1638909A2 (en) Process for preparing alkoxy- and aryloxy-phenols
JP3765394B2 (ja) 水中アルドール反応方法
JPH08169868A (ja) 4−シアノ−4’−ヒドロキシビフェニルの製造方法
JP2547089B2 (ja) カルボン酸類の製法
CN111592465A (zh) 一种制备2-氨基-4-氨甲基苯甲酸甲酯及其盐酸盐的方法
IE780470L (en) Benzylidene halides
JPH11255720A (ja) 芳香族アミンの製造方法
JPH07103069B2 (ja) β−アセトナフトンの選択的製造方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: ZAMBON GROUP S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAIOCCHI, MAURIZIO;BELLI, ALDO;PONZINI, FRANCESCO;AND OTHERS;REEL/FRAME:013725/0268;SIGNING DATES FROM 20021021 TO 20021125

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: ZACH SYSTEM S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZAMBON GROUP S.P.A.;REEL/FRAME:019649/0001

Effective date: 20070101